For: | Chen JH, Yu YS, Chen XH, Liu HH, Zang GQ, Tang ZH. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen. World J Gastroenterol 2012; 18(12): 1319-1327 [PMID: 22493545 DOI: 10.3748/wjg.v18.i12.1319] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i12/1319.htm |
Number | Citing Articles |
1 |
Xiaohua Chen, Yuyan Tang, Yi Zhang, Meng Zhuo, Zhenghao Tang, Yongsheng Yu, Guoqing Zang. Tapasin modification on the intracellular epitope HBcAg18–27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo. Laboratory Investigation 2014; 94(5): 478 doi: 10.1038/labinvest.2014.6
|
2 |
Siyuan Ma, Xiaohua Chen, Quanhui Tan, Dan Li, Shenglan Dai, Shanshan Wu, Yongsheng Yu, Guoqing Zang, Zhenghao Tang. An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells. Cell Cycle 2018; 17(10): 1220 doi: 10.1080/15384101.2018.1471312
|
3 |
Shenglan Dai, Xiaohua Chen, Yongsheng Yu, Guoqing Zang, Zhenghao Tang. Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9487
|
4 |
LINLIN SONG, MENG ZHUO, YUYAN TANG, XIAOHUA CHEN, YONGSHENG YU, ZHENGHAO TANG, GUOQING ZANG. Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro. Molecular Medicine Reports 2015; 12(1): 289 doi: 10.3892/mmr.2015.3352
|
5 |
MENG ZHUO, LINLIN SONG, YUYAN TANG, SHENGLAN DAI, XIAOHUA CHEN, YONGSHENG YU, GUOQING ZANG, ZHENGHAO TANG. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice. Molecular Medicine Reports 2015; 12(3): 3591 doi: 10.3892/mmr.2015.3834
|
6 |
Weiguo Zhu, Hui Yan, Shan Li, Wencheng Nie, Fangyan Fan, Jianhua Zhu. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways. International Immunopharmacology 2016; 41: 24 doi: 10.1016/j.intimp.2016.09.028
|
7 |
Yong Liu, Rui Huang, Yali Xiong, Qi Zhao, Guangmei Chen, Juan Xia, Chao Wu. Soluble CD40 ligand-activated B cells from patients with chronic hepatitis B virus infection as antigen presenting cells to induce hepatitis B virus specific cytotoxic T lymphocytes. Biochemical and Biophysical Research Communications 2014; 450(1): 61 doi: 10.1016/j.bbrc.2014.05.080
|
8 |
Weixia Chen, Lei Wang, Yaofei Niu, Guang Ji, Lianjun Xing. Distribution of peripheral dendritic cells in patients with HBV infection or spleen and kidney deficiency. Journal of Medical Virology 2018; 90(4): 706 doi: 10.1002/jmv.24998
|
9 |
Negar Seyed, Tahereh Taheri, Charline Vauchy, Magalie Dosset, Yann Godet, Ali Eslamifar, Iraj Sharifi, Olivier Adotevi, Christophe Borg, Pierre Simon Rohrlich, Sima Rafati, Clive M. Gray. Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine. PLoS ONE 2014; 9(10): e108848 doi: 10.1371/journal.pone.0108848
|
10 |
Huixia Cui, Wenlu Zhang, Wei Hu, Kun Liu, Tong Wang, Nan Ma, Xiaohui Liu, Yunpeng Liu, Youhong Jiang, Sophia N. Karagiannis. Recombinant Mammaglobin A Adenovirus-Infected Dendritic Cells Induce Mammaglobin A-Specific CD8+ Cytotoxic T Lymphocytes against Breast Cancer Cells In Vitro. PLoS ONE 2013; 8(5): e63055 doi: 10.1371/journal.pone.0063055
|
11 |
Feng Wang, Lie Mao, Hongyan Hou, Shiji Wu, Min Huang, Botao Yin, Jing Huang, Qin Zhu, Yingying Pan, Ziyong Sun. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients. International Immunopharmacology 2016; 32: 39 doi: 10.1016/j.intimp.2016.01.012
|
12 |
Linlin Song, Meng Zhuo, Yuyan Tang, Xiaohua Chen, Zhenghao Tang, Guoqing Zang. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo. International Immunopharmacology 2014; 23(1): 1 doi: 10.1016/j.intimp.2014.08.006
|
13 |
Xuan Wang, Fang-Cheng Zhang, Hong-Yang Zhao, Xiao-Ling Lu, Yun Sun, Zhi-Yong Xiong, Xiao-Bing Jiang. Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model. Tumor Biology 2014; 35(8): 7781 doi: 10.1007/s13277-014-1867-3
|
14 |
Shenglan Dai, Meng Zhuo, Linlin Song, Xiaohua Chen, Yongsheng Yu, Guoqing Zang, Zhenghao Tang. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice. Immunobiology 2016; 221(7): 813 doi: 10.1016/j.imbio.2016.01.015
|